landiolol has been researched along with Cardiomyopathy, Hypertrophic Obstructive in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Cho, Y; Inoue, K; Kunimoto, M; Minamino, T | 1 |
Abe, T; Goto, K; Hagiwara, S; Hidaka, S; Noguchi, T; Uchino, T; Yamamoto, S; Yasuda, N | 1 |
Kuro, M; Nohmi, T; Ohnishi, Y; Shinzawa, M; Tsuzuki, M | 1 |
3 other study(ies) available for landiolol and Cardiomyopathy, Hypertrophic Obstructive
Article | Year |
---|---|
Haemodynamic effects of acute intravenous landiolol in Takotsubo cardiomyopathy with dynamic left ventricular outflow tract obstruction.
Topics: Cardiomyopathy, Hypertrophic; Hemodynamics; Humans; Mitral Valve; Mitral Valve Insufficiency; Takotsubo Cardiomyopathy; Ventricular Outflow Obstruction; Ventricular Outflow Obstruction, Left | 2023 |
Effective control of paroxysmal tachycardia with landiolol hydrochloride during cesarean section in a patient with hypertrophic obstructive cardiomyopathy.
Topics: Adult; Anti-Arrhythmia Agents; Cardiomyopathy, Hypertrophic; Cesarean Section; Elective Surgical Procedures; Female; Hemodynamics; Humans; Morpholines; Postoperative Complications; Pregnancy; Tachycardia, Paroxysmal; Urea | 2010 |
[Successful weaning from cardiopulmonary bypass with administration of landiolol hydrochloride in a patient with hypertrophic obstructive cardiomyopathy].
Topics: Adolescent; Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Cardiomyopathy, Hypertrophic; Cardiopulmonary Bypass; Catheter Ablation; Humans; Intra-Aortic Balloon Pumping; Male; Morpholines; Urea | 2005 |